Recent publications · Crossref
5 total works indexed
- Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
· 2020 · cited 1,086x
- Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
· 2020 · cited 970x
- Exercise and insulin resistance in type 2 diabetes mellitus: A systematic review and meta-analysis
· 2019 · cited 377x
- Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)
· 2021 · cited 367x
- Integrated multimodal cell atlas of Alzheimer’s disease
· 2024 · cited 284x
via Crossref · CC0